In 2025, **** percent of sponsors identified the United States as a preferred destination for outsourcing and expansion in the coming years. Despite fluctuations over time, the United States remained the leading choice for biopharmaceutical outsourcing.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Bourne Partners. (February 11, 2026). U.S. as a preferred biopharma outsourcing destination from 2009 to 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/1662147/potential-biopharma-outsourcing-destination-us/
Bourne Partners. "U.S. as a preferred biopharma outsourcing destination from 2009 to 2025." Chart. February 11, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/1662147/potential-biopharma-outsourcing-destination-us/
Bourne Partners. (2026). U.S. as a preferred biopharma outsourcing destination from 2009 to 2025. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/1662147/potential-biopharma-outsourcing-destination-us/
Bourne Partners. "U.S. as a Preferred Biopharma Outsourcing Destination from 2009 to 2025." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Feb 2026, /statistics/1662147/potential-biopharma-outsourcing-destination-us/
Bourne Partners, U.S. as a preferred biopharma outsourcing destination from 2009 to 2025 ÌÇÐÄÆƽâ°æ, /statistics/1662147/potential-biopharma-outsourcing-destination-us/ (last visited July 23, 2026)
U.S. as a preferred biopharma outsourcing destination from 2009 to 2025 [Graph], Bourne Partners, February 11, 2026. [Online]. Available: /statistics/1662147/potential-biopharma-outsourcing-destination-us/
